p120 is now well established as a key regulator of classical cadherins and a modulator of Rho- GTPases. At cell-cell junctions, p120 is essential for cadherin stability, and appears to control cell-cell adhesion in part by regulating cadherin stability at the cell surface. Other lines of evidence indicate roles in a variety of Rho-mediated activities that control cell morphology, motility, and proliferation. These observations imply critical roles for p120 in cell-cell adhesion and tumor progression. For all known p120 activities aside from cadherin stabilization, regulation is critically dependant on the N-terminal 300 amino acid segment termed the """"""""regulatory domain"""""""". p120 mutants lacking this region (e.g, p120-4 isoforms) are dominant active or dominant negative, depending on the action being assayed (e.g, cell-cell adhesion vs. cell motility). It is increasingly evident that the regulatory domain is required for coupling to Rho, which may in turn account for many of the effects of p120 in cells. The regulatory domain also contains the majority of approximately 16 tyrosine (Y) and serine/threonine (S/T) phosphorylation sites, and interacts with several tyrosine-kinases (e.g, PER, Fyn, Yes) and -phosphatases (eg, PTPa, DEP1, SHP1). Collectively, these observations suggest several potential mechanisms for signaling input and output that are likely to modulate p120 and cadherin activity, and outline what we believe to be the mechanical underpinnings of p120 regulation. Nonetheless, it is not yet clear how the N-terminus controls p120 activity or and/or coupling to Rho. Our working hypothesis is that most of p120's key roles in adhesion and cancer are regulated via protein-protein interactions and post-translational modifications of its regulatory domain. To address this issue in vitro and in vivo, we have generated a powerful p120 siRNA knockdown/substitution model system, mapped the major p120 phosphorylation sites, generated panels of p120 phospho-specific antibodies, and created a p120 conditional knockout mouse. To clarify the role of the regulatory domain, we propose in aim 1 to molecularly dissect the region by uncoupling key p120 binding partners and by structure-function analyses of phosphorylation site mutants.
In aim 2, we will use our novel p120 phospho-specific antibodies to identify and study the upstream signaling pathways and direct-acting upstream phospho-effectors of p120 function.
Aim 3 is to develop a strategy for determining the molecular mechanism by which p120 regulates RhoA. It examines the phenotypic consequences of fibroblast targeted p120 ablation in vitro and in our conditional KO mouse.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-ICI-G (01))
Program Officer
Woodhouse, Elizabeth
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Vanderbilt University Medical Center
Anatomy/Cell Biology
Schools of Medicine
United States
Zip Code
Yu, Huapeng H; Dohn, Michael R; Markham, Nicholas O et al. (2016) p120-catenin controls contractility along the vertical axis of epithelial lateral membranes. J Cell Sci 129:80-94
Markham, Nicholas O; Doll, Caleb A; Dohn, Michael R et al. (2014) DIPA-family coiled-coils bind conserved isoform-specific head domain of p120-catenin family: potential roles in hydrocephalus and heterotopia. Mol Biol Cell 25:2592-603
Markham, Nicholas O; Cooper, Tracy; Goff, Matthew et al. (2012) Monoclonal antibodies to DIPA: a novel binding partner of p120-catenin isoform 1. Hybridoma (Larchmt) 31:246-54
Smith, Andrew L; Dohn, Michael R; Brown, Meredith V et al. (2012) Association of Rho-associated protein kinase 1 with E-cadherin complexes is mediated by p120-catenin. Mol Biol Cell 23:99-110
Naydenov, Nayden G; Brown, Bryan; Harris, Gianni et al. (2012) A membrane fusion protein ?SNAP is a novel regulator of epithelial apical junctions. PLoS One 7:e34320
Kurley, Sarah J; Bierie, Brian; Carnahan, Robert H et al. (2012) p120-catenin is essential for terminal end bud function and mammary morphogenesis. Development 139:1754-64
Smith, Andrew L; Friedman, David B; Yu, Huapeng et al. (2011) ReCLIP (reversible cross-link immuno-precipitation): an efficient method for interrogation of labile protein complexes. PLoS One 6:e16206
Smalley-Freed, Whitney G; Efimov, Andrey; Short, Sarah P et al. (2011) Adenoma formation following limited ablation of p120-catenin in the mouse intestine. PLoS One 6:e19880
Stairs, Douglas B; Bayne, Lauren J; Rhoades, Ben et al. (2011) Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene. Cancer Cell 19:470-83
Carnahan, Robert H; Rokas, Antonis; Gaucher, Eric A et al. (2010) The molecular evolution of the p120-catenin subfamily and its functional associations. PLoS One 5:e15747

Showing the most recent 10 out of 21 publications